Abstract
Cisplatin is an antineoplastic molecule extensively used in the treatment of breast, cervical, esophageal, bladder, lung and testicular cancers, and a potent nephrotoxic agent responsible for the induction of acute kidney injury (AKI), with a focus on tubular injury. To date, little is known about the effect of cisplatin on the cellular mechanisms responsible for tubular injuries. On the …